|
Market Closed -
Swiss Exchange
09:00:17 11/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 112.04 CHF | -0.09% |
|
-13.54% | +2.23% |
| 12/09 | Scholar Rock gets first FDA nod for rare muscle-wasting disease | RE |
| 12/09 | US FDA approves Scholar Rock's muscle weakness drug | RE |
| Market Cap | 26TCr 22TCr 21TCr 19TCr 36TCr 24,93800Cr 36TCr 2,52900Cr 97TCr 12,68700Cr 98TCr 96TCr 40,09100Cr | P/E 2026 * |
19.4x | P/E 2027 * | 16.3x |
|---|---|---|---|---|---|
| Enterprise Value | 29TCr 25TCr 24TCr 22TCr 41TCr 27,95500Cr 41TCr 2,83500Cr 1,09000Cr 14,22200Cr 1,09900Cr 1,07500Cr 44,94100Cr | EV / Sales 2026 * |
5.08x | EV / Sales 2027 * | 4.71x |
| Free-Float |
91.66% | Yield 2026 * |
3.21% | Yield 2027 * | 3.35% |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| NOVN | Delayed | |
CBOE
| 0QLR | Real-time | |
|
OTC Markets
| NVSEF | Delayed | |
|
London S.E.
| 0QLR | Delayed | |
|
Borsa Italiana
| 1NOVN | End-of-day quote | |
|
Tradegate
| NOT | Real-time | |
|
Xetra
| NOT | Delayed | |
|
Xetra
| NOT | End-of-day quote | |
|
Deutsche Boerse AG
| NOT | End-of-day quote | |
|
Boerse Muenchen
| NOT | Real-time | |
|
Börse Stuttgart
| NOT | Delayed | |
|
Deutsche Boerse AG
| NOT | Delayed | |
|
Mexican S.E.
| NOVN N | End-of-day quote | |
|
CBOE
| 0QLR | Real-time | |
|
Wiener Boerse
| NOVN | End-of-day quote | |
|
CBOE
| Real-time |
Last Transcript : Novartis AG
| 1 day | -0.09% | ||
| 1 week | -13.54% | ||
| Current month | -9.10% | ||
| 1 month | -9.79% | ||
| 3 months | -8.22% | ||
| 6 months | -7.28% | ||
| Current year | +2.23% |
| 1 week | 110.3 |  | 127.22 |
| 1 month | 110.3 | | 132.68 |
| Current year | 107.68 | | 132.68 |
| 1 year | 96.03 | | 132.68 |
| 3 years | 81.1 | | 132.68 |
| 5 years | 72.84 | | 132.68 |
| 10 years | 65.09 | | 132.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/02/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 16/03/2026 |
Karen Hale
CMP | Compliance Officer | 58 | 14/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 01/01/2015 |
| Director/Board Member | 69 | 01/01/2016 | |
Ton Büchner
BRD | Director/Board Member | 61 | 01/01/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/05/26 | Sell | -5,200 | 0.0003% | |||
| 04/05/26 | Sell | 6,800 | 0.0003% | |||
| 17/02/26 | Sell | 30,743 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.09% | -13.54% | +13.34% | +24.95% | 26TCr | |
| -0.65% | -2.93% | +47.70% | +86.17% | 99TCr | |
| -0.29% | -3.51% | +49.15% | +62.35% | 64TCr | |
| +0.83% | +0.26% | +17.76% | +72.25% | 45TCr | |
| -0.38% | -3.59% | +30.13% | +35.17% | 34TCr | |
| -0.43% | -2.48% | -0.73% | +9.58% | 25TCr | |
| -1.34% | -13.70% | +36.53% | +44.96% | 20TCr | |
| -3.44% | -7.51% | -20.63% | -59.44% | 19TCr | |
| -0.75% | -4.82% | +25.46% | +87.14% | 18TCr | |
| +0.25% | -2.57% | +16.13% | -18.83% | 16TCr | |
| Average | -0.63% | -5.44% | +21.49% | +34.43% | 36.63TCr | |
| Weighted average by Cap. | -0.47% | -4.34% | +30.32% | +51.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.76TCr 4.97TCr 4.7TCr 4.26TCr 8TCr 5,50700Cr 8.04TCr 56TCr 21TCr 2,80200Cr 22TCr 21TCr 8,85300Cr | 6.13TCr 5.28TCr 5TCr 4.53TCr 8.51TCr 5,85800Cr 8.55TCr 59TCr 23TCr 2,98000Cr 23TCr 23TCr 9,41700Cr |
| Net income | 1.42TCr 1.22TCr 1.16TCr 1.05TCr 1.97TCr 1,35600Cr 1.98TCr 14TCr 5.29TCr 69TCr 5.33TCr 5.21TCr 2,17900Cr | 1.57TCr 1.36TCr 1.28TCr 1.16TCr 2.18TCr 1,50400Cr 2.2TCr 15TCr 5.87TCr 77TCr 5.91TCr 5.78TCr 2,41800Cr |
| Net Debt | 3.16TCr 2.72TCr 2.58TCr 2.34TCr 4.38TCr 3,01700Cr 4.4TCr 31TCr 12TCr 1,53500Cr 12TCr 12TCr 4,85100Cr | 2.79TCr 2.4TCr 2.28TCr 2.06TCr 3.87TCr 2,66500Cr 3.89TCr 27TCr 10TCr 1,35600Cr 10TCr 10TCr 4,28400Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | CHF 112.04 | -0.09% | 28,03,406 |
| 10/26/10 | CHF 112.14 | +0.43% | 32,79,444 |
| 09/26/09 | CHF 111.66 | -0.13% | 43,17,913 |
| 08/26/08 | CHF 111.80 | -10.89% | 1,04,30,648 |
| 07/26/07 | CHF 125.46 | -3.18% | 31,16,102 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
